Loading comparison data...
Medical Disclaimer: This site provides informational comparisons only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your physician or pharmacist before making medication decisions.
Compare NILOTINIB (nilotinib) and RYDAPT (RYDAPT) — clinical data, side effects, and patient experiences.
nilotinib · Targeted Cancer Therapy
How it works
12.1 Mechanism of Action Nilotinib is an inhibitor of the BCR-ABL kinase. Nilotinib binds to and stabilizes the inactive conformation of the kinase domain of ABL protein. In vitro ...
Approved for
RYDAPT · Targeted Cancer Therapy
How it works
12.1 Mechanism of Action Midostaurin is a small molecule that inhibits multiple receptor tyrosine kinases. In vitro biochemical or cellular assays have shown that midostaurin or it...
Approved for
Estimated frequency (%) based on clinical trial data
Based on 8 Reddit discussions
NILOTINIB
13%
positive
8 threads
RYDAPT
0%
positive
0 threads
% of discussions mentioning each side effect
8 Reddit threads analysed for NILOTINIB
Overall Sentiment
Mixed
Comparison Threads
2
Avg Post Score
15 upvotes
Most discussed side effects in community
Threads directly comparing NILOTINIB to other medications
Just looking for some people who have been on either of these and their experiences! I started Dasatinib 100mg for my CML and it worked well for reducing my WBC and BCR-ABL. However, I was only on it for about 2 months as the side effects were pretty intolerable. Really severe bone pain, fatigue, he
Has anyone had any issues switching from brand to generic TKIs? Specifically Tasgina to Nilotinib. Counts have been good for a decade but now insurance making me change to Nilotinib. I know it’s basically the same med (just different fillers) but wanted to see if anyone had experience with it? Thank
Hi, the European Leukemia Net published its 2025 update of recommendations for the treatment of CML recently, you can find it on the internet ([2025 European LeukemiaNet recommendations for the management of chronic myeloid leukemia | Leukemia](https://www.nature.com/articles/s41375-025-02664-w)). T
Hey everyone, I’m 10 months into a chronic phase CML diagnosis with no detectable mutation. I started on Nilotinib, then moved to Dasatinib (up to 140mg), but my BCR’s been stuck around 20% and hasn’t dropped enough. Starting Ponatinib on Monday. If that doesn’t work, the plan is Asciminib, then tra
Hi guys, My husband has been living with CML for around 20 years now (age 36). He had been on Imatinib fot a long time, before he got changed on Nilotinib in 2020. Since he changed medication, his blood tests had always been stable (grade 4 or 4.5) until a few months ago, where he suddenly got to g
I'm about 6 months post diagnosis, and 4 months into TKIs (Tasigna 600mg daily). Super grateful to be TKI sensitive, with BCR-ABL1 down from 41% to .0066%, but now starting to process what life will be like living with CML and nilotinib. Fatigue and dry, itchy skin have been the main side effects so
Hello! Diagnosed with CML July 2024 and been taking Imatinib. However, for the past 6 months my CBC is not normal. My doctor decided to change tki to Nilotinib 600mg. Anyone who uses Nilotinib? It it better? My I know the side effects that you experience? Thank you 🙂
I’m 25 yo male diagnosed w cp cml in dec 2022. Responded well to nilotinib for 4 months with a hematologic relapse recently. Confirmed T315I mutation. Doc suggests ponatinib until we can schedule a bone marrow transplant. Anybody had similar experiences? What does my prognosis look like? Thanks for
Community discussions are sourced from public Reddit threads. Content reflects individual opinions and is not medical advice.
No community discussions found for RYDAPT yet.
Both NILOTINIB and RYDAPT belong to the Targeted Cancer Therapy class. While they share a similar mechanism of action, differences in pharmacokinetics, dosing, and side effect profiles may make one more suitable than the other for individual patients.
NILOTINIB carries 4 FDA warnings. RYDAPT carries 4 FDA warnings. Patients should discuss all warnings and contraindications with their healthcare provider before starting or switching medications..
This comparison is for informational purposes only. Always consult a qualified healthcare professional before making medication decisions.